Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in Cardiovascular dealmaking
2.1. Introduction
2.2. Cardiovascular partnering over the years
2.3. Cardiovascular partnering by deal type
2.4. Cardiovascular partnering by industry sector
2.5. Cardiovascular partnering by stage of development
2.6. Cardiovascular partnering by technology type
2.7. Cardiovascular partnering by therapeutic indication

Chapter 3 –Financial deal terms for Cardiovascular partnering
3.1. Introduction
3.2. Disclosed financials terms for Cardiovascular partnering
3.3. Cardiovascular partnering headline values
3.4. Cardiovascular deal upfront payments
3.5. Cardiovascular deal milestone payments
3.6. Cardiovascular royalty rates

Chapter 4 – Leading Cardiovascular deals and dealmakers
4.1. Introduction
4.2. Most active in Cardiovascular partnering
4.3. List of most active dealmakers in Cardiovascular
4.4. Top Cardiovascular deals by value

Chapter 5 – Cardiovascular contract document directory
5.1. Introduction
5.2. Cardiovascular partnering deals where contract document available

Chapter 6 – Cardiovascular dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by Cardiovascular therapeutic target

Appendices
Appendix 1 – Directory of Cardiovascular deals by company A-Z 2014 to 2020
Appendix 2 – Directory of Cardiovascular deals by deal type 2014 to 2020
Appendix 3 – Directory of Cardiovascular deals by stage of development 2014 to 2020
Appendix 4 – Directory of Cardiovascular deals by technology type 2014 to 2020
Further reading on dealmaking
Deal type definitions

About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from CurrentPartnering

Table of figures
Figure 1: Cardiovascular partnering since 2014
Figure 2: Cardiovascular partnering by deal type since 2014
Figure 3: Cardiovascular partnering by industry sector since 2014
Figure 4: Cardiovascular partnering by stage of development since 2014
Figure 5: Cardiovascular partnering by technology type since 2014
Figure 6: Cardiovascular partnering by indication since 2014
Figure 7: Cardiovascular deals with a headline value
Figure 8: Cardiovascular deals with upfront payment values
Figure 9: Cardiovascular deals with milestone payment
Figure 10: Cardiovascular deals with royalty rates
Figure 11: Active Cardiovascular dealmaking activity– 2014 to 2020
Figure 12: Top Cardiovascular deals by value since 2014

Companies mentioned
1A Pharma, 3PrimeDx, 4D Molecular Therapeutics, 4D Pharma, 4SC Discovery, 36 Strategies General Trading, 480 Biomedical, A&D Medical, A&E Medical, A*STAR Agency for Science, Technology and Research, AADi, Abbott Laboratories, Abbott Vascular Devices, Abiomed, Ab Medica, Abyrx, Acasti Pharma, Accenture, Access Scientific, Access Vascular, ACEA Biosciences, Acino Pharma, Actelion, Actuated Cardio Engineering, Actuated Medical, Acutus Medical, ADAS 3D Medical, AddUp, Admedus, Admera Health, Advanced BioScience Laboratories, Advanced Cardiac Therapeutics, Advanced Catheter Therapies, Advanced Cooling Therapy, Adventus Ventures, Aegerion Pharmaceutical, Aerolase, Agena Bioscience, Agilent Technologies, Akcea Therapeutics, Akers Biosciences, Akrimax Pharmaceutical, Akums Drugs and Pharmaceuticals, Alibaba Health, AliveCor, Allegiance Health Foundation, Allergan, Alliance Medical, Alnylam Pharmaceuticals, Altrix Medical, Amarin, Amarna Therapeutics, American College of Emergency Physicians, American College of Physicians Foundation, American College of Surgeons, American Heart/Stroke Association, American Heart Association, AmeriCares, Amgen, Amneal Pharmaceuticals, AmorChem, Amos Gazit, AnaBios, Analog Devices, AnaMar, Angel Medical Systems, AnGes MG, Angiodynamics, Angion Biomedica, Angionetics, AngioSoma, ANI Pharmaceuticals, Antares Pharma, Antaros Medical, Anthem, Anthos Therapeutics, AOP Orphan Pharmaceuticals, APAC Scientific, Apicore, Aplagon, Apollo Hospitals Group, Apotex, Apple, Applied Medical, Aptahem, Aralez Pharmaceuticals, Ardelyx, Arena Pharmaceuticals, argenx, Argon Medical Devices, Armetheon, Aronora, Arrowhead Pharmaceuticals, Arteriae, Arterial Health International, Arterial Remodeling Technologies, Asahi Intecc, Ashland-Boyd County Health Department, ASKA Pharmaceuticals, Aspen Global, Aspen Holding, Aspire Health Science, Astellas Pharma, AstraZeneca, AstraZeneca HealthCare Foundation, Atelerix, Athersys, Atnahs Pharma, AutoGenomics, Autotelic, Aviir Diagnostics, Awamedica, Axiogenesis, Axol Bioscience, Aziyo Biologics, Baker IDI Heart and Diabetes Institute, Bardy Diagnostics, Baxter International, Bayer, Bayer Healthcare, Bay Labs, B Braun, Beijing Leadman Biochemistry, Beijing SL Pharma, Bellerophon Therapeutics, Bened Biomedical, Berg, Bertin Pharma, Bicycle Therapeutics, Bina Technologies, BioCardia, Bioengineering Laboratories, Biofourmis, BioHeart, BioLamina, BIOLIFE4D, BioLife Solutions, Biomerics, BioSig Technologies, Biostar, Biostar Pharmaceuticals, Biotectix, BioTelemetry, Biotricity, Biotronik, BioVectra, Bioventix, Biovic Sdn bhd, Bird Foundation, BlueRock Therapeutics, BodyTrace, Boehringer Ingelheim, Boryung Pharmaceutical, Boston Medical Center, Boston Pharmaceuticals, Boston Scientific, Breckenridge Pharmaceuticals, Brigham and Women’s Hospital, Brigham Young University, Bristol-Myers Squibb, Broad Institute, Brooks Automation, Burgerhospital, Cadila Pharmaceuticals, Caladrius Biosciences, California Institute for Regenerative Medicine, California Institute of Technology, Canadian Institutes of Health Research, Capellabio, Capricor Therapeutics, Caprion Proteomics, Cardiac Insight, Cardiac Life, Cardinal Health, CardiNor, Cardio3 Biosciences Asia Holdings, CardioDx, CardioFocus, CardioLogic, Cardiome Pharma, Cardiorentis, Cardiovascular Cell Therapy Research Network, Cardiovascular Research Foundation, Cardiovascular Systems, Cardiowise, Cardium Therapeutics, Cardurion Pharmaceuticals, CareDx, CareLearning, Carestream Health, CareTaker Medical, Carmat, Carmel Pharma, Carrum Health, Casebia Therapeutics, Case Western Reserve University, CASI Pharmaceuticals, CAS Medical Systems, Catherine’s Health Center, Catheter Precision, CDC Foundation, Cedars-Sinai Health System, Cedars-Sinai Medical Center, Celgene, Celladon, Cell and Gene Therapy Catapult, CELLINK, CellProThera, Cell Therapy, Celltrion, Cellular Logistics, CeloNova BioSciences, Celyad, Center for Biomarker Research in Medicine, Center for Connected Health, Centers for Medicare and Medicaid Services, Centron Diagnostics, Cevec Pharmaceuticals, Chameleon BioSurfaces, Charles River Laboratories, Chek Diagnostics, Chiesi Farmaceutici, Children’s Heart Foundation, Children’s Hospital Boston, Children’s Hospital of Philadelphia, Children’s Medical Research Institute, Children’s Hospital Oakland Research Institute (CHORI), China Grand Pharmaceutical, China Medical System, Chinese Future Industry Investment Fund, Chinese Society of Cardiology, Chong Kun Dang, Christiana Care Health System, Cilag AG, C Illies, CinCor Pharma, Cipher Pharmaceuticals, Cipla Medpro, Citius Pharmaceuticals, Clarity Pharmaceuticals, ClearFlow, Cleveland Clinic, Cleveland HeartLab, Clinlogix, Coeptis Pharmaceuticals, Cofactor Genomics, Colibri Heart Valve, College of Life Science of Northwest University, Columbia University Medical Center, Conavi Medical, Concordia Healthcare, Contatti Medical, Cook Medical, Coqui RadioPharmaceuticals, Cordis, CorDynamics, CoreRx Pharma, Corindus Vascular Robotics, CorMatrix Cardiovascular, Coroneo, CorpMedical, Correvio, CorVascular, Corvia Medical, Corvida Medical, Corvidia Therapeutics, Covalon Technologies, Covance, Covidien, Covis Pharmaceutical, Cranford Pharmaceuticals, CRISPR Therapeutics, Critical Diagnostics, Crown Bioscience, Cryolife, CSL, Cure Duchenne, CVie, CyberHeart, Cyclenium Pharma, Cynata Therapeutics, Cytori Therapeutics, CytoSorbents, Daewoong Pharmaceutical, Daiichi Sankyo, DalCor Pharmaceuticals, Dalhousie University, Dassault Systems, DaVinci Biomedical Research Products, DecImmune Therapeutics, deCODE Genetics, Delta, Deltex Medical, Denovo Biopharma, Department of Defense, Department of Health and Human Services, Dewpoint Therapeutics, Diablo Clinical Research, diaDexus, DiA Imaging Analysis, Diaxonhit, Dicerna Pharmaceuticals, DiNAQOR, Dizal Pharmaceutical, Dogma Therapeutics, Domainex, Dorizoe Lifesciences, Dr. Reddy’s Laboratories, Drukier Institute for Children’s Health, DSM, Duke-NUS Graduate Medical School Singapore, Duke Clinical Research Institute (DCRI), Duke University, Duke University Medical Center, Eagle Pharmaceuticals, EB Neuro, eCardio Diagnostics, Eddingpharm, Edwards Lifesciences, Eiger BioPharmaceuticals, Eko, ELC Group, Electrical Geodesics, Elexopharm, Eli Lilly, Elkhorn Logan Valley Public Health Department, Embolitech, EmboMedics, Emory University, Enamine, Endo International, Endologix, Endospan, Endotronix, Enterprise Partners Venture Capital, ENYO Pharma, Epsilon, Erasmus University Medical Center, ERS Genomics, ERT, Esaote, Esperion Therapeutics, Espero Pharmaceuticals, Eurolab Especialidades Medicinales de Eurofar, European Commission, European Innovation Council, Event Cardio Group, Everest Medicines, Excelera Network, Exelixis, Expression Analysis, ExScientia, FABPulous, Feinstein Institute for Medical Research, FEops, FibriCheck, Fine Foods & Pharmaceuticals N.T.M., First Check Diagnostics, FitBit, Food and Drug Administration (FDA), Foundation for Community Partnerships, Frankfurt University Hospital, FSD Pharma, Fujifilm, Fujifilm medical systems, Fundacion Progreso y Salud, Fu Wai Hospital, G3 Pharmaceuticals, Galenicum Health, Gardia Medical, Gatehouse Bio, GC Pharma, GE Healthcare, Geisinger Medical Center, Gemphire, Genetrix, Genomas, Genomic Vision, Genpharm, Genzyme, George Clinical, George Washington University, German Ministry for Education and Research, Gestion Univalor, Getinge, Global Genomics Group, Guangdong Provincial People’s Hospital, Guerbet, H2-Pharma, Hadasit Medical Research Services and Development, Hainan Savy Akers Biosciences, Hainan Savy Investment Management, Hainan Sihuan Pharmaceutical, Hanmi Pharmaceutical, Hansen Medical, Harbin Gloria Pharmaceuticals, Harpoon Medical, Harvard Apparatus Regenerative Technology, Harvard Pilgrim Health Care, Harvard Stem Cell Institute, Harvard University, Healios K.K., Healthcare Technology Innovation Centre (Chennai), HealthCore, Health Sciences Research Institute Germans Trias i Pujol Foundation, Healthstream, HealthTrust, HealthTrust Purchasing Group, Heartflow, HeartGenetics, HeartHero, HeartIT, Heart Rhythm Society, Helix, HemCon Medical Technologies, HemispheRx Biopharma, Hemostasis, Hemostemix, Henry Ford Health System, Henry Schein, Hetero Labs, Hibernation Therapeutics, Hikma Pharmaceuticals, HLH BioPharma Vertriebs, HLS Therapeutics, HoliStick Medical, Holmdel Pharmaceuticals, Horizon 2020, Horizon Discovery, Hospices Civils de Lyon, Hospital of University of Strasbourg, Huami, Huapont Pharma, Humacyte, Human Biosystems, iBIO Institute’s PROPEL Center, Icahn School of Medicine at Mount Sinai, iCardiac Technologies, Icon, Idorsia, Ikaria, ImagineMIC, Impax Laboratories, ImpediMed, Imperial College London, Imricor Medical Systems, Independent Medical Coop, Indiana Biosciences Research Institute, Indiana University, Indigo Biosciences, InfoBionic, InfraReDx, inHEART, Innovate UK, Innovation Network Corporation, Innovative Genomics Initiative (IGI), INO Therapeutics, iNova Pharmaceuticals, Insilico, InspireMD, InSpire MD, Inspyr Therapeutics, Insulet, Integer Holdings, Integrated DNA Technologies, Interleukin Genetics, Intermountain Healthcare, Interrad Medical, InterValve, INVAP, inVentiv Health, Invitae, Ionis Pharmaceuticals, iRhythm Technology, ISA Scientific, Itamar Medical, Jackson Laboratory, Jacksonville Pharmaceuticals, Jai Capital, JanOne, Janssen Biotech, Janssen Pharmaceuticals, Janssen Research & Development, Japan Lifeline, Jarvik Heart, Jasper Capital, JNC Medical, Johns Hopkins Medicine (JHM), Johns Hopkins University, Johnson & Johnson, Johnson & Johnson Innovation, Juvise Pharmaceuticals, Jvion, Kaneka, Kastle Therapeutics, Kennedy Trust For Rheumatology Research, Keystone Heart, King’s College Hospital, Kiniksa Pharmaceuticals, Kissei Pharmaceutical, Kitov, Knight Therapeutics, KOL Bio Medical Instruments, Konica Minolta, Korea Animal Medical Science Institute, Kowa, Kowa Pharmaceuticals America, Kuhnil Pharmaceuticals, Kyoto University, Kyowa Hakko Kirin, Laboratory Corporation of America, La Jolla Capital, La Jolla Pharmaceutical, Lannett, Lantheus Medical Imaging, Lanxess, Lee’s Pharmaceutical, Leiden University, Leiters, LeMaitre Vascular, Leonhardt’s Launchpads, Leviticus Cardio, Lexington Biosciences, Life-Assist, LifeArc, LifeQ, LifeWatch Services, Ligand Pharmaceuticals, LindaCare, Linear Health Sciences, LivaNova, Lokai Medical, Lombard Medical Technologies, Lonza, LORION Enterprises, LSU Health Sciences Center, Lund University, Lupin Limited, Luye Pharma Group, M2S, MagBioSense, Magnesium Elektron, Magnum Cell Therapies, Mallinckrodt Pharmaceuticals, Mallory Community Health Center, Manna Ministries, Maquet Medical Systems, Marina Biotech, Marizyme, Masimo, Massachusetts General Hospital, Massachusetts Institute of Technology, Materialise, Matthew Walker Comprehensive Health Center, Max-Planck, Mayo Clinic, MC3 Cardiopulmonary, MD Anderson Cancer Center, MedAxiom, MedCision, Medeon Biodesign, Medicall Biomedikal, Medicure, MedImmune, Medipal Holdings, MediSafe, Mediso, Medison, Medison Pharma, Medisun International, Meditrade, Medline Industries, Medovex, MedPac Asia Pacific, Medtronic, Mentice, Merck and Co, Merck KGaA, Merck Serono, Merge Healthcare, Merus Labs International, Mesoblast, Mespere LifeSciences, Metabasis Therapeutics, Metactive, Metrion Biosciences, Mezzion Pharma, Micell Technologies, Micro Interventional Devices, Micro Medical Solutions, MicroPort Scientific, MicroPort Sorin CRM (Shanghai), Millar, Millipede, Ministry of Health (Saudi Arabia), Minnetronix, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical, Moderna Therapeutics, Molecular Stethoscope, Montreal Heart Institute, Morphic Therapeutic, Mperia Therapeutics, MRI Interventions, MSC, MSN Laboratories, Myant, Mylan Laboratories, Myocarditis Foundation, MyoKardia, Myriad RBM, myTomorrows, N8 Medical, Nanion, NASA, National Cancer Center, National Center for Cardiovascular Diseases, National Heart, Lung and Blood Institute, National Institute of Neurological Disorders and Stroke, National Institute on Drug Abuse (NIDA), National Institutes of Health, National Institutes of Health Center for Regenerative Medicine, National Organization for Rare Disorders, National Physical Laboratory, National Research Council Industrial Research Assistance Program, National Science Foundation, National University of Singapore, Navidea Biopharmaceuticals, Ncardia, NeoChord, Neograft Technologies, Neovasc, NeuroproteXeon, Neurotrope BioScience, NeuroVive Pharmaceutical, NeuroVive Pharmaceutical Asia, New England Research Institutes, New York Genome Center (NYGC), NGM Biopharmaceuticals, Nido Surgical, Nightingale Health, Nihon Kohden, Nissan Chemical Industries, Noden Pharma, Nonin Medical, North Carolina State University, North Georgia Healthcare, Northwestern Medicine Bluhm Cardiovascular Institute, Northwestern Medicine Developmental Therapeutics Institute, Northwestern University, Novant Health, Novartis, Novasep, Novation, Novella Clinical, Novoheart, Novo Nordisk, Novostia, NuCryo Vascular, NuMed, Numerate, Nutricare Costa Rica, NuVascular Technologies, Nuvo Pharmaceuticals, Oberland Capital, Ohio State University, Olympus, OMEICOS Therapeutics, Omthera Pharmaceuticals, On-X Life Technologies, One Drop, OnFace, Ontario Institute for Cancer Research, Opsens, OptiBiotix, Optina Diagnostics, Optum Labs, OrbusNeich, Orchestra BioMed, Orebro University, ORIG3N, Orphan Canada, Ortho-Clinical Diagnostics, Oscor, Otsuka, Owlstone Medical, OxySure Systems, Palmetto Project, Paragonix Technologies, Parent Project Muscular Dystrophy, Patheon, Patient-Centered Outcomes Research Institute (PCORI),, Paul G Allen Family Foundation, Pax Neuroscience, PDL BioPharma, PEDRA Technology, Peking University, Penn Medicine, Penumbra, PeptiDream, Pfizer, Pharmabiota, Pharmaceutical Research and Manufacturers of America, Pharma Scientific Research, Pharnext, PhaseBio Pharmaceuticals, Philips, PhoreMost, Pierre Fabre, Pivotal Therapeutics, Pluriomics, Pluristem Therapeutics, Pohl Boskamp, Poxel, Precision Image Analysis, Premier Inc, Preora Diagnostics, Preventice, Preventice Inc, Procella Therapeutics, Procter & Gamble, Procyrion, Profil Institute for Clinical Research, Profusa, Project HOPE, Proteros biostructures, ProtoKinetix, ProvideGx, Proximo Medical, Pulsion Medical Systems, Punjab Province, Q3 Medical Devices, QT Vascular, Quest Diagnostics, Quintiles, QuiO Technologies, Rain Therapeutics, Raisio, RayBiotech, Recordati, ReCor Medical, Recovery Force, ReFlow Medical, Regenerative Medicine of China, Regenerative Medicine of Latin America, Regeneron Pharmaceuticals, Regents of the University of Michigan, Regenxbio, Relevium, Relias, Relypsa, Renova Therapeutics, Renovo, Research Development Foundation, Resverlogix, Retrophin, Retroscreen Virology, Rexgenero, Rex Medical, RFPi, Rigel Pharmaceuticals, Rijuven, Rimidi, Roche, Rocket Pharmaceuticals, Roxwood Medical, Royal Philips Electronics, RQI Partners, RTI Surgical, Rush University Medical Center, SACCO, Saint Agnes Hospital Foundation, Saint Luke’s Mid America Heart Institute, Salutron, Sanbor Medical, Sanford Burnham Institute, Sanford Health, Sankofa Community Development, Sanofi, Schrodinger, SciCann Therapeutics, SciClone Pharmaceuticals, ScinoPharm Taiwan, Scohia Pharma, scPharmaceuticals, Selenity Pharmaceuticals, Selvita, Sensible Medical Innovations, Serenus Biotherapeutics, Service and Medical Colombia, Shanghai Institutes for Biological Sciences, Shanghai Model Organisms Center, Shenzhen Hepalink Pharmaceutical, Shionogi, Shire Pharmaceuticals, SHL Telemedicine, Siemens Healthineers, SignaBlok, SignPath Pharmaceuticals, Silver Creek Pharmaceuticals, Sinclair Research, Sinotherapeutics, Sintact Medical Systems, SK Telecom, Small Business Innovation Research, Smart Medical Systems, Smartwise, SNBL CPC, Society for Vascular Surgery Patient Safety Organization (SVS PSO), Somahlution, SomaLogic, Sonic Healthcare, Sophia Genetics, Sorin Group, Sosei, Sosei Heptares, Southwest Research Institute, Spectranetics, Spectrum Pharmaceuticals, Sphingotec, SQI Diagnostics, SQ Innovation, St. Mary Medical Center, STADA Arzneimittel, Stanford University, Stanford University School of Medicine, Staten Biotechnology, Stem Cell Theranostics, Stentys, Stereotaxis, St Jude Medical, Sumocor, Sundance Research Institute, SunTech Medical, SuperSonic Imagine, SurModics, Svelte Medical Systems, Swedish Bactiguard, Swixx Biopharma, Symplmed Pharmaceuticals, SynCardia Systems, Tabuk Pharmaceutical, TaiGen Biotechnology, Takeda Pharmaceutical, Talis Biomedical, TARA Biosystems, Taros Chemicals, Tasly Pharmaceuticals, Taxus Cardium Pharmaceuticals, Taxus Pharmaceuticals, Technology Strategy Board (UK), Teijin, Tel Aviv University, Teleflex, Terason, Tersus Life Sciences, Terumo, Terumo BCT, Terumo Cardiovascular Systems, Teva Pharmaceutical Industries, The Food Trust, The Hospital for Sick Children, The Medicines Company, Theorem Clinical Research, Theraclion, Theragene Pharmaceuticals, TheraVasc, Thermo Fisher Scientific, The University of Chicago Medicine, Third Pole Therapeutics, Tibet Rhodiola Pharmaceutical Holding Co, TiGenix, TogetherMD, Topstone Research, Toray, Toronto Innovation Acceleration Partners, toSense, Toshiba America Medical Systems, TRACON Pharmaceuticals, Transcatheter Technologies, Transgenomic, Translational Sciences, Trigen, TriReme Medical, Tufts Medical Center, Turing Pharmaceuticals, twoXAR, Typenex Medical, UAB Research Foundation, Ubiquigent, UCB, UDG Healthcare, Unetixs Vascular, Unify Surgical, Unilife, UniQure, United Imaging Healthcare, United Therapeutics, UnityPoint Health, University College London, University of British Columbia, University of California Los Angeles, University of California San Francisco, University of Cambridge, University of Cincinnati, University of Colorado, University of Colorado Denver, University of Copenhagen, University of Dundee, University of Iowa, University of Maryland, University of Maryland Baltimore, University of Miami, University of Nebraska, University of Ottawa, University of Oxford, University of Pennsylvania, University of Pittsburgh, University of Reading, University of Sydney, University of Utah, University of Wisconsin, USCI Holdings, Valeant Pharmaceuticals, Vance Street Capital, Vasamed, Vascugen, Vascular Flow Technologies, Vascular Graft Solutions, Vascutek, Vasomune Therapeutics, Vasorum, Venclose, Venus Medtech, Verily, Viamet Pharmaceuticals, Vianex, Viant, Viking Therapeutics, Virginia Catalyst, VirtualScopics, Vital Connect, Vitruvias Therapeutics, Viva Biotech, VivaQuant, VivoSense, Vizient, Vygon, Wacker Biotech, Wake Forest University, WakeMed Health & Hospitals, Wallace H. Coulter Foundation, Washington University in St Louis, Weill Cornell Medical College, Wellbridge Health, Wellcome Trust Sanger Institute, West Pharmaceutical Services, Whittier Street Health Center, Winthrop-University Hospital, WomenHeart, Worcester Polytechnic Institute (WPI), World Heart Federation, WuXi PharmaTech, X-chem, XCellCure, Xention, Yale University, Yiling Wanzhou International Pharmaceuticals, Yissum Research Development, ZAO Firma Euroservice, Zealand Pharma, ZeClinics, Zhittya Genesis Medicine, Zoll Medical